For this purpose we compared levels of circulating methylated RASAL1 promoter DNA fragments in patients with comparable stage of chronic kidney disease due to malignant arterial hypertension (HTN) with or without Dihydralazine treatment (Supplementary Table E). The gene discussed is RASAL1; the disease is hypertensive disorder.